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Abst rac t  
Background and purpose: Neuromodulative treatment of chro -
nic pain syndromes is a modern mode of treatment of neu-
ropathic and ischaemic pain. Its effectiveness is well docu-
mented in the literature. The objective of this work is to present
the results of treatment of chronic pain syndromes on the ba-
sis of eight-year experience in our department.
Material and methods: Since 2002, we have conducted 
9 operations of motor cortex stimulation (MCS), 2 of deep
brain stimulation (DBS), 45 of spinal cord stimulation
(SCS) and 5 of sacral root stimulation (SRS) in the treatment
of chronic pain.
Results: We obtained good long-term results of neuromo -
dula tion in the form of clinical improvement (> 50%) in 4 of
9 pa tients with MCS (44%), in 13 diagnosed with failed back
surgery syndrome (FBSS), 8 with other neuropathic pain, and
11 with angina pectoris from a group of 45 treated with SCS.
Sacral root stimulation has been successful in 3 of 5 patients with
perianal pain. The best treatment results in SCS, although not
statistically significant, were observed in patients treated due to
FBSS (13 out of 15) and angina pectoris (11 out of 15) 
(p = 0.12). In patients with neuropathic pain, peripheral and
central, improvement was obtained in 8 out of 15 patients.
Conclusions: A good indication for spinal cord stimulation 
is FBSS and angina pectoris. Motor cortex stimulation is help-
ful in the treatment of chronic central neuropathic pain. Fur-
ther observations and a larger group of patients are necessary
for a reliable assessment of the effectiveness of neuromodu-
lative treatment of chronic pain in our clinic.
Results of neuromodulation for the management of chronic pain
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St reszczenie
Wstêp i cel pracy: Neuromodulacyjne leczenie bólu przewlek³ego
to nowoczesna forma leczenia bólu neuropatycznego i niedo-
krwiennego. Jego efektywnoœæ zosta³a dobrze udokumentowana
w piœmiennictwie. Celem pracy jest przedstawienie wyników
leczenia przewlek³ych zespo³ów bólowych na podstawie oœmio-
letniego doœwiadczenia kliniki autorów.
Materia³ i metody: Od 2002 r. w leczeniu bólu przewlek³ego
przeprowadzono 9 zabiegów stymulacji kory mózgu (MCS),
2 g³êbokiej stymulacji mózgu (DBS), 45 stymulacji rdzenia
krêgowego (SCS) i 5 stymulacji korzeni krzy¿owych (SRS).
Wyniki: Otrzymano dobre odleg³e wyniki neuromodulacji
w postaci poprawy klinicznej (co najmniej o 50%) u 4 spoœród
9 pacjentów z MCS (44%), u 13 z rozpoznaniem dyskopatii
lêdŸwiowej (FBSS) oraz u 8 z innym bólem neuropatycznym,
a tak¿e u 11 z dusznic¹ bolesn¹ z grupy 45 poddanych SCS.
Stymulacja korzeni krzy¿owych by³a skuteczna u 3 spoœród
5 pacjentek z bólem okolicy oko³oodbytniczej. Najlepsze 
wyniki leczenia, choæ nieznamienne statystycznie, zaobser-
wowano w SCS u pacjentów leczonych z powodu zespo³u 
bólowego krêgos³upa o typie FBSS (13 spoœród 15 pacjentów)
oraz d³awicy piersiowej (11 spoœród 15) (p = 0,12). W gru-
pie pacjentów z bólem neuropatycznym obwodowym i oœrod-
kowym poprawê uzyskano u 8 spoœród 15 osób. 
Wnioski: Dobrymi wskazaniami do stymulacji rdzenia krêgo-
wego s¹ przewlek³y zespó³ bólowy o typie FBSS i dusznica 
bolesna. Stymulacjê kory mózgu mo¿na z powodzeniem sto-
sowaæ w leczeniu oœrodkowego bólu neuropatycznego. Do prze-
prowadzenia wiarygodnej oceny skutecznoœci leczenia 
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Introduction
Since the introduction of gate theory by Melzack and
Wall in 1965 and performance of the first spinal cord 
sti mulation procedure by Shealy et al. in 1967, hundreds
of investigators and clinicians have proceeded with
neuromodulative procedures and a plethora of publica-
tions have revealed positive effects of this kind of treat-
ment in chronic pain [1,2]. Neuromodulative procedures
are superior to neuroablative approaches in two main 
aspects: they are reversible and safe. The following neu-
romodulative procedures are the most common in chro -
nic pain: peripheral nerve stimulation (PNS), spinal cord
stimulation (SCS), deep brain stimulation (DBS), mo-
tor cortex stimulation (MCS), and the intrathecal infu-
sion system (IIS). Sacral root stimulation (SRS), targeted
neurostimulation (TNS), drug-enhanced spinal cord
stimulation and procedures combining two methods, e.g.
SCS and targeted subcutaneous stimulation [3-5], play
an important role in specific pain syndromes.
The mechanism of action of all neuromodulative 
approaches in chronic pain has not yet been fully eluci-
dated. There are several plausible analgesic effects of spinal
cord stimulation. The first theory explains inhibition of
transmission of nociceptive impulses by activation of large
dorsal fibres in dorsal horns; electric stimulation can cause
segmental inhibition or activation of the anterior pretectal
nucleus. Linderloth postulates a mechanism activating
GABA-b receptors, which suppresses the excitatory, 
nociceptive effect in dorsal horn cells; other neuro-
transmitters such as serotonin, glycine and adenosine are
to play a pivotal role in inhibition of neuropathic pain.
In ischaemic pain, besides chemical action, autonomic 
activity of SCS, especially suppression of sympathetic 
excitation, is crucial [6-8]. In MCS and DBS, sup-
pression of transmission of nociceptive stimuli in thala-
mic nuclei might be the factor responsible for pain
diminution [9-12].
The main indication for neuromodulation is neuro-
pathic and ischaemic pain [13-20]. Several particular
methods are characteristic and the most suitable for 
appropriate types of pain. Motor cortex stimulation is
a method applicable in neuropathic pain of thalamic 
syndrome, post-stroke pain, in pain after spinal cord 
injury or brachial plexus injury, in atypical facial pain and
atypical trigeminal neuralgia [11,21-25]. Similar in-
 dications, and additionally cluster headache, exist for 
DBS [12,26-28]. Spinal cord stimulation is in widespread
use in failed back surgery syndrome (FBSS), chronic
radicular pain, complex regional pain syndrome (CRPS),
phantom limb pain, postherpetic neuralgia, peripheral vas-
cular disease and angina pectoris [3,13,14,16-19,29-32].
Patients with occipital neuralgia and trigeminal neural-
gia are qualified for PNS; other targets of nerve stimu-
lation are median, radial, ulnar and tibial nerves; pelvic
pain is an indication for SRS [5,33].
We always have to remember about proper selection
of patients for neuromodulative procedures. The outcome
of operative neuromodulation is conditioned by factors such
as aetiology, timing of implantation, the sort of electrodes
and type of pulse generator, programming and tolerance
on pain development [18,32,34,35]. For instance, in SCS,
the most satisfactory results can be achieved in neuropathic
pain of FBSS and CRPS, also in refractory angina or pe-
ripheral vascular disease. Worse outcomes are in phantom
pain, postherpetic neuralgia, pain due to spinal cord in-
jury and perirectal pain or axial pain. The success rate is
higher in cases with a shorter time interval between the 
beginning of chronic pain and the time of implantation.
Better pain reduction of axial pain is achieved when dual
electrodes are applied in SCS than single leads [34]. Over
the years, techniques of operative neuromodulation have
undergone significant changes and modernization. New
strategies are less invasive, more popular and less costly.
The most popular is SCS, which is available in the majority
of departments of neurosurgery in Poland. In our de-
partment we started to conduct neuromodulative strate-
gies for chronic pain in 2002, although we had performed
neuroablative procedures previously [36].
Material and methods
Since 2002, 9 procedures of MCS, 2 of DBS, 45 of
SCS and 5 of sacral stimulation have been performed in
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neuromodulacyjnego bólu przewlek³ego w klinice autorów nie-
zbêdne s¹ dalsze obserwacje i wiêksza grupa pacjentów pod-
danych ró¿nym procedurom.
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cja rdzenia krêgowego, stymulacja kory mózgu.
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the Department of Neurosurgery of the Military Cli nical
Hospital.
The group of patients qualified for MCS consisted
of patients with chronic neuropathic pain of thalamic syn-
drome caused by stroke, intracerebral haemorrhage,
multiple sclerosis, pain associated with syringomyelia,
chronic pain due to brachial plexus injury and atypical 
facial pain. All MCS implantations were done under 
general anaesthesia without muscular relaxation, with cra -
niotomies contralateral to the pain side; electrodes were
placed on dura and in four cases directly on the motor cor-
tex guided by neuronavigation and neurophysiological 
neuromonitoring (Fig. 1). Monitoring of motor evoked
potentials (MEP), and in several cases somatosensory
evoked potentials (SSEP), enabled us to localize the mo-
tor and sensory cortex and central sulcus. Pulse genera-
tors connected by wires to electrodes were implanted in
subcutaneous pockets in the subclavicular area.
In DBS, we used a stereotactic frame and BrainLab
Iplan software which enables planning of stereotactic 
implantation of deep brain electrodes. In both our cas-
es we localized tips of electrodes in the posterior part of
the internal capsule. The target proposed by Richardson
seemed to be the most suitable for us [37]. Deep brain
stimulation implantations were performed in local anaes-
thesia under fluoroscopic control [38].
Spinal cord stimulation is a pain procedure conducted
in pain clinics and neurosurgical departments. In our de-
partment, we generally implant paddle type electrodes 
surgically, placing them on the dural sac after central
flavectomy or partial laminectomy anchoring leads to fas-
cia, connecting to an internal pulse generator placed in
a subcostal, subcutaneous pocket on the right or left side.
These procedures are performed under general anaes-
thesia. Nowadays, we generally do a one-stage operation
of spinal cord stimulator implantation. We believe that
a second operation after a trial period with external sti -
mulation can be avoided in the majority of cases. An even-
tual second intervention is necessary when a paddle type
electrode is placed in the wrong place, i.e. slightly too 
laterally, or at the wrong level. It is important to point out
here that a percutaneous procedure under local anaesthesia
is superior due to the possibility of intraoperative stim-
ulation, but it is less convenient for the patient and 
there is a higher risk of lead electrode migration. In pain
located in lower legs and in the lumbar area, we usual-
ly implant electrodes at the Th10 level, in angina pectoris
at the Th2 level, in intercostal neuralgia at the appropriate
Th level above, in pain comprising upper limbs at 
C2-3 levels. In four cases, percutaneous electrodes
were implanted through the sacral hiatus in order to sti -
mulate sacral roots in perianal pain (Fig. 2). All patients
were hospitalized several days after surgery and para-
meters of stimulation were adjusted individually.
Among 15 patients with angina pectoris, 2 were
women, 13 men, 10 had experienced myocardial infarc -
tion before. All patients were qualified for SCS due to
in effective pharmacotherapy and when all the possibi -
lities of revascularisation procedures had been complet-
ed. All had undergone cardiological, cardiosurgical
and neurosurgical consultations confirming the diagnosis
and proper qualification. 
Effects of treatment were assessed on a visual analogue
scale. Intensity of pain was assessed after surgery, one
month after surgery and later on every 3 or 6 months.
Not all patients were able to attend scheduled visits. In
many cases, information about effects of neuromodula-
tion was obtained by telephone. Presented results describe
the state of efficacy in various patients with different 
periods of observation (from 3 months to 8 years) in Au-
tumn 2010.
Results
Effects of motor cortex stimulation
Nine patients were operated on; in two patients (one
with atypical facial pain, the other with pain related to
brachial plexus injury) we had no improvement, in three
Fig. 1. Motor cortex stimulation in thalamic pain located in lower and upper
extremities. Two four-polar electrodes placed on precentral gyrus and in
interhemispheric fissure
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cases (two with thalamic syndrome, the third with
hemibody pain related to syringomyelia) we obtained less
than 50% improvement, in four patients (two cases with
thalamic syndrome and two with atypical facial pain) we
observed over 50% long-term improvement (including
two cases with 90% improvement). In the last subgroup,
in two cases we placed electrodes directly on the cortex
subdurally. These patients were able to significantly 
reduce doses of analgesics, mostly tramadol. Patients with
neuropathic pain also used gabapentin and carbama zepine
additionally.
Effects of spinal cord stimulation in neuropathic pain
Among 30 patients with SCS due to neuropathic pain
(excluding patients with angina pectoris), we had no 
improvement in five cases: two cases with pain related
to spinal cord injury, one patient with pain caused by
myelitis, one patient with phantom pain and another one
with pain due to brachial plexus injury. In other four cas-
es (one with intercostal neuralgia, two with anal pain and
one with neuropathic pain due to conus medullaris in-
jury) preliminary good effects deteriorated to a worse re-
sponse, which was estimated as a lack of any improve-
ment. In 8 patients (26%) with follow-up longer than 
12 months we observed worsening of the initial satisfactory
effect which later was assessed as a moderate effect with
improvement of less than 50% (patients with FBSS, 
syringomyelia and CRPS type 2). A good long-term re-
sult of neuromodulation in the form of clinical impro -
 vement (at least 50%) was obtained in 13 patients diag-
nosed with FBSS and 8 patients with other neuropath-
ic pain. The best treatment results in SCS, although not
statistically significant, were observed in patients treat-
ed due to FBSS (13 out of 15 patients, 86%) (p = 0.12).
In other patients with neuropathic pain, peripheral or cen-
tral, significant improvement was noted in 8 patients out
of 15 (53%). Patients who had an excellent result usu-
ally did not use analgesics; frequently they reduced dos-
es and even withdrew nonsteroidal drugs and tramadol.
Others, with worse effects, had to sustain anal gesics, an-
tidepressants and anxiolytic drugs.
Effects of spinal cord stimulation in angina pectoris
Fifteen patients with angina pectoris treated with 
SCS remained satisfied in long-term follow-up. All pa-
tients after implantation achieved significant alleviation
of pain, in 11 patients (73%) alleviation was complete
(VAS = 0). Reduction of incidence of anginal attacks
and improvement of physical capacity was observed.
Standard exercise tests and scintigraphy tests revealed
improved myocardial perfusion with increased total ejec-
tion fraction. In all patients, doses of long-acting nitrates
were decreased. Neurostimulator caused reduction of ad-
 ministered nitrates with complete withdrawal of them in
40% (6 patients) [39,40]. They used short-acting ni-
trates very seldom. Two patients died, one due to pul-
monary embolism and the second by suicide. Statistical
analysis documented reduction of costs of refractory angi-
na pectoris treatment after stimulator implantation. 
In five years perspective, costs of treatment were de-
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creased by 41%. The cost of the neurostimulator and its
implantation should be returned in 10 years [41].
Effects of sacral root stimulation
Five patients with chronic perianal and rectal pain were
treated with SRS. In one patient two methods were 
applied: first, conus medullaris stimulation; secondly, 
SRS. Operations were performed under general anaes-
thesia and electrodes were implanted under fluorosco -
pic control percutaneously through the sacral hiatus. 
Satisfactory results have been achieved – improvement
around or over 50% in three cases [42]. 
Complications
In 9 MCS procedures, we had 3 events of epileptic
seizures during intraoperative stimulation and one event
postoperatively; after reduction of stimulation parame-
ters it did not occur again. No other complications were
observed in MCS. In DBS we noted one event of mi-
gration of an electrode 2 months after implantation and
lack of stimulation effects. In the stereotactic procedure,
the main complications are intracerebral haemorrhage 
(below 5%) [12] and increased risk of infection (up to
12%) [12,43] or annoying paraesthesias [28]. In SCS
procedures we had two cases of epidural haematoma in
the spinal canal which had to be evacuated. One was
symptomatic with paraparesis. It was the patient with angi-
na pectoris who had been receiving antiplatelet drugs pre-
operatively. We noted one case of breakage of a lead due
to increased tension in the place where it was connect-
ed to the electrode lead. Three times we had to change
the position of the electrode due to insufficient coverage
of the area of pain. In two cases it was necessary to re-
move the stimulation system due to infection after SRS
procedures. 
Discussion
Neuromodulation therapy modulates activity of the
nervous system and is a highly specific and reversible
mode of treatment of pain of various origin. Neu-
rostimulation devices involve the application of electrodes
into or on the brain, over the spinal cord or to periph-
eral nerves. The most common worldwide and in
Poland is SCS to treat chronic neuropathic pain. The best
indications for SCS are neuropathic pain and ischaemic
pain in coronary artery disease and peripheral vascular
disease [20,32,44]. In our department, patients treated
with SCS constitute the majority of patients managed 
with neuromodulation due to chronic neuropathic pain
or angina.
According to our experience and the experience of 
others, a key to success is the right choice of patient and
the right choice of indication [32,34,44]. Patients with
long-standing pain have lower chance of a successful 
effect than those who do not wait for implantation so long
[32,34]. In our material, all patients who had a poor re-
sult had had a long history of pain before implantation
(mean: 9 years). Patients with significant improvement
had mean pain duration of 6.8 years. We have not found
a statistically significant difference in the Cochran-Cox
test between these groups, probably due to the small num-
ber of subjects in both groups. Another very important
factor influencing the final effect is the aetiology of pain.
Worse results have been observed in neuropathic pain 
associated with central nervous system injury, i.e. anaes-
thesia dolorosa in MCS and DBS, pain due to spinal cord
haematoma or spinal cord injury and brachial root
avulsion, postherpetic intercostal neuralgia or phantom
pain. We have not found a statistically significant rela-
tionship between FBSS, angina pectoris and other types
of pain and the result (p = 0.12). The best effects can
be achieved in patients with FBSS and angina pectoris.
This statement remains in accordance with the obser-
vations of others having much greater material [32,34,44].
Distribution of pain is also another crucial factor. It is
much easier to alleviate pain localized in the extremities,
and it is rarely possible to remove axial pain in the mid-
lumbar area or in the scrotal and anal region using 
SCS [14,19,32]. Patients with perianal pain are quali-
fied for SRS.
In our department, patients are scheduled to be fol-
lowed up every 3 months. The majority of them attend
the control visit due to aggravation of symptoms or lack
of perception of paraesthesias produced by the stimula-
tor. According to our experience, patients usually have
a problem with proper estimation of intensity of pain and
grade of improvement. They have difficulties with 
objective assessment of effects of stimulation after modi-
fication of parameters. It is much easier for them to de-
termine the area of paraesthesias induced by the sti mulator.
In some cases it is possible to cover the area of pain with
stimulation; thus we can reduce the level of pain but not
enough to satisfy the patients. In our material, 21/30 pa-
tients with SCS (excluding angina) had a satisfactory ef-
fect (over 50%) or almost satisfactory effect (40-50%).
These data are changing all the time because some pa-
tients are never certain in their subjective assessment. On
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the other hand, among them there are people who are con-
vinced of the beneficial influence of SCS. In general, ef-
fects of SCS in our patients are positive and only one pa-
tient after 3 years of successful analgesic therapy asked
us to remove the internal power generator (IPG) due to
unpleasant paraesthesias affecting the whole body. 
Effectiveness of SCS is estimated at around 65% [30].
The percentage of patients with FBSS who have clinical
improvement over 50% is about 50-62%, 40% of patients
return to work activities, 70% can feel satisfaction, and
53% of patients withdraw analgesic drugs [18,19]. 
Better results can be achieved in CRPS type 2 (causal-
gia) and type 1 (reflex sympathetic dystrophy), 79-82%,
or in peripheral ischaemic pain, over 70% [17] and 
especially in angina pectoris. Around 80% of patients 
experience significant long-term improvement of com-
fort of life and increase in social activity with a reduction
of the number of anginal attacks [16].
Complications associated with SCS can be divided
into surgical complications, which are infection, CSF
leakage, epidural haemorrhage, and mechanical spinal
cord injury (5-9%) [44]; and the second group of com-
plications, associated with breakage of the lead, migra-
tion or transposition of the electrode and IPG. The lat-
ter are more frequent and account for about 10-30% 
of patients [30,44]. The diminution of effects of sti -
mulation is caused by development of tolerance of pain
and underlying disease. The median percentage of hard-
ware failures was calculated to be 6.5%, ranging from
0 to 40% [19,44].
Among nine patients who were treated with MCS,
complete lack of improvement was noted in two patients:
one with neuropathic pain caused by avulsion of the
brachial plexus, the second with long-lasting anaesthe-
sia dolorosa in the trigeminal area. According to the data
of others, satisfactory results can be achieved in central
pain and neuropathic trigeminal pain [23]. In our ma-
terial we have one female patient with atypical facial pain
with significant improvement of at least 50% who had
reimplantation of the IPG due to depletion of the bat-
tery. An excellent result can be observed in one patient
with thalamic syndrome who has one electrode implanted
subdurally along the motor cortex, following patients with
two electrodes: one placed subdurally in the interhemi-
spheric fissure and the second implanted on the dura 
estimate the effect as satisfactory around 40% to 50% on
the lower and upper extremity (Fig. 1). In MCS, stimu-
lation is set at a lower frequency than in SCS (40-50 Hz)
and a shorter pulse wave (100-140 ms); amplitude is 
adjusted to the level which prevents epileptic seizure 
occurrence. Paraesthesias are rarely perceived in MCS.
Satisfactory long-term improvement is observed in
three cases in patients with central neuropathic pain, but
our group consists only of 9 subjects and it is difficult to
draw plausible conclusions.
Conclusions
1. A good indication for SCS is FBSS and angina pectoris.
2. The majority of patients with chronic pain experience
relief of pain after stimulation.
3. Motor cortex stimulation is helpful in central neuro-
pathic pain.
4. Patients should remain under control of the neuro-
surgical centre for follow-up and periodic changes in
the parameters of stimulation.
5. Further observations and a larger group of patients 
undergoing different procedures are necessary for 
a reliable assessment of the effectiveness of neuro-
modulative treatment of chronic pain in our clinic. 
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